MEET BERYL

Improving Bone Health Using Skeletal Lipidomics

Beryl is developing small molecules which are currently under investigation for multiple applications related to bone mineral density.  The portfolio includes compounds with nutritional uses for supporting bone health and therapeutic uses aimed at reversing osteoporosis. 

 

The compounds have a unique with a dual mechanism of action, are orally bio-available and are composed of GRAS compounds.

HU-639 is suitable for use as a nutritional supplement (DSHEA), medical food or food additive.  The compound is endogenous - found naturally in bone and in olive oil. 

HU-671 - is being investigated as a therapeutic. 

Our A+ team is very experienced in bone, osteoporosis drugs and nutrition. 

As we develop these products, we are leveraging data for human and veterinary fields of use.

Beryl Health Platform
Beryl 2.png

© 2020 to 2025 by Beryl Therapeutics Inc. All Rights Reserved.